Prophylaxis of Patent Ductus Arteriosus with Paracetamol in Extremely Low Gestational Age Newborns (ELGANs): A Single-Institution Observational Study in Vietnam
Introduction: Prophylactic paracetamol for extremely low gestation age neonates (ELGAN, <27 weeks’ gestation) with symptomatic patent ductus arteriosus (sPDA) in high-income countries (HIC) reduces medical and surgical interventions. Its effectiveness in low-to-middle-income countries (LMIC) rema...
Main Authors: | Tinh Thu Nguyen, Dung Thi Ngoc Nguyen, Tam Thi Thanh Pham, Ju-Lee Oei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/10/12/1934 |
Similar Items
-
Management of Patent Ductus Arteriosus in Premature Infants in 2020
by: Sarah Parkerson, et al.
Published: (2021-02-01) -
Patent Ductus Arteriosus Device Closure with AMPLATZER Duct Occluder-II in a Low Birth Weight Preterm Neonate- First Experience in Pakistan
by: Sana Imtiaz, et al.
Published: (2023-05-01) -
Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams
by: Alain Fraisse, et al.
Published: (2020-09-01) -
Patent Ductus Arteriosus (P.D.A.) (An analysis of 37 surgically proved cases)
by: O. J. Rachman, et al.
Published: (2019-09-01) -
Correlation between the Closure Time of Patent Ductus Arteriosus in Preterm Infants and Long-Term Neurodevelopmental Outcome
by: Natsumi Kikuchi, et al.
Published: (2024-01-01)